Cell Growth & Differentiation, Vol 3, Issue 8 485-494, Copyright © 1992 by American Association of Cancer Research

ARTICLES

12-O-tetradecanoylphorbol-13-acetate induces transient cell cycle arrest in G1 and G2 in metastatic melanoma cells: inhibition of phosphorylation of p34cdc2

DL Coppock, JB Tansey and L Nathanson
Oncology Research Laboratory, Winthrop University Hospital, Mineola, New York 11501.

The growth of Demel human metastatic melanoma cells was inhibited by 12-O-tetradecanoylphorbol-13-acetate (TPA) and other nonphorbol tumor promoters including palytoxin and okadaic acid. Using flow cytometry, we have demonstrated that the cells arrested growth in G1 and G2 phases of the cell cycle. Detailed analysis of the kinetics of the growth arrest in unsynchronized cells showed that (a) the growth arrest was transient and peaked 16-20 h following addition of TPA; (b) effects of TPA on cell growth began within 1-2 h after the addition; and (c) cells completed S phase and arrested in G2. In addition, TPA induced a pronounced morphological change, which peaked by 1 h and gradually subsided over 24 h. In populations of cells synchronized in G1 using lovastatin, (a) addition of TPA blocked the onset of DNA synthesis up to the end of G1; (b) the lag between addition of the drug and onset of DNA synthesis was less than 30 min; and (c) addition of TPA at the end of G1 prevented the increased phosphorylation of p34cdc2, as determined by immunoprecipitation. The experiments reported here show that TPA transiently blocked the proliferation of Demel melanoma cells at the G1-S border and in G2, thus preventing cells from progressing through the cell cycle. These experiments suggest that pathways involving protein kinase C interact with and rapidly alter the molecular pathways involving p34cdc2 which regulate the onset of DNA synthesis and the G2-M transition.

This article has been cited by other articles:

				S.-J. Cozzi, P. G. Parsons, S. M. Ogbourne, J. Pedley, and G. M. Boyle Induction of Senescence in Diterpene Ester-Treated Melanoma Cells via Protein Kinase C-Dependent Hyperactivation of the Mitogen-Activated Protein Kinase Pathway. Cancer Res., October 15, 2006; 66(20): 10083 - 10091. [Abstract] [Full Text] [PDF]

				A. W. Ashton, G. Watanabe, C. Albanese, E. O. Harrington, J. A. Ware, and R. G. Pestell Protein Kinase Cdelta Inhibition of S-Phase Transition in Capillary Endothelial Cells Involves the Cyclin-dependent Kinase Inhibitor p27Kip1 J. Biol. Chem., July 23, 1999; 274(30): 20805 - 20811. [Abstract] [Full Text] [PDF]

				M. R. Frey, M. L. Saxon, X. Zhao, A. Rollins, S. S. Evans, and J. D. Black Protein Kinase C Isozyme-mediated Cell Cycle Arrest Involves Induction of p21waf1/cip1 and p27kip1 and Hypophosphorylation of the Retinoblastoma Protein in Intestinal Epithelial Cells J. Biol. Chem., April 4, 1997; 272(14): 9424 - 9435. [Abstract] [Full Text] [PDF]

				J. Y. Lee, Y. A. Hannun, and L. M. Obeid Functional Dichotomy of Protein Kinase C (PKC) in Tumor Necrosis Factor-alpha (TNF-alpha ) Signal Transduction in L929 Cells. TRANSLOCATION AND INACTIVATION OF PKC BY TNF-alpha J. Biol. Chem., September 15, 2000; 275(38): 29290 - 29298. [Abstract] [Full Text] [PDF]